Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer.

Cancer investigation - 1 Oct 2010

Erfani Nasrollah, Razmkhah Mahbobeh, Ghaderi Abbas

Abstract excerpt

Soluble CTLA4 (sCTLA4) was assessed in sera of 43 new cases with breast cancer and 44 age- and sex-matched healthy individuals by enzyme-linked immunosorbent assay method. Associations of sCTLA4 levels with the six important CTLA4 Single Nucleotide Polymorphisms (SNPs) and with the resulted haplotypes were investigated. Results revealed significant concentration of sCTLA4 in patients with breast cancer (23.5 ±...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal

Share to CTLA-4 Antigen

Share to Enzyme-Linked Immunosorbent Assay

Share to Patient Selection

Share to Reference Values

Source

Identifiers

PMID: 20482250
DOI: 10.3109/07357901003630934

Genes

CTLA4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer.PMID 20482250Read ↗

Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.Semantic proximity Read ↗

Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes.Semantic proximity Read ↗

Circulating Cytotoxic T lymphocytes associated antigen-4 (CTLA-4) levels and CTLA-4 gene polymorphism role in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour immunitySemantic proximity Read ↗

Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.Semantic proximity Read ↗

Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast China.Semantic proximity Read ↗

Genomic regulation of CTLA4 and multiple sclerosis.Semantic proximity Read ↗

Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.Semantic proximity Read ↗

Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.Semantic proximity Read ↗

Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.Semantic proximity Read ↗

The soluble CTLA-4 receptor and its role in autoimmune diseases: an updateSemantic proximity Read ↗

Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.